Cargando…
Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus
BACKGROUND: Manifestations in neuropsychiatric systemic lupus erythematosus (NPSLE), especially active diffuse NPSLE syndromes, are some of the most difficult complications of the disease. For the evaluation and the diagnosis of central nervous system manifestations, including NPSLE, MRI is a very u...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225739/ https://www.ncbi.nlm.nih.gov/pubmed/25396069 http://dx.doi.org/10.1136/lupus-2014-000050 |
_version_ | 1782343561810804736 |
---|---|
author | Arinuma, Yoshiyuki Kikuchi, Hirotoshi Wada, Tatsuhiko Nagai, Tatsuo Tanaka, Sumiaki Oba, Hiroshi Hirohata, Shunsei |
author_facet | Arinuma, Yoshiyuki Kikuchi, Hirotoshi Wada, Tatsuhiko Nagai, Tatsuo Tanaka, Sumiaki Oba, Hiroshi Hirohata, Shunsei |
author_sort | Arinuma, Yoshiyuki |
collection | PubMed |
description | BACKGROUND: Manifestations in neuropsychiatric systemic lupus erythematosus (NPSLE), especially active diffuse NPSLE syndromes, are some of the most difficult complications of the disease. For the evaluation and the diagnosis of central nervous system manifestations, including NPSLE, MRI is a very useful tool to detect the various abnormalities. However, the relationship between brain MRI findings and clinical variables has not yet been clarified in patients with diffuse NPSLE. OBJECTIVES: The aim of this study is to investigate the pathogenesis of diffuse NPSLE, by comparing various parameters such as serum autoantibodies and cytokines in cerebrospinal fluid (CSF) with abnormal findings revealed on brain MRIs in patients with diffuse NPSLE. METHODS: Fifty-three patients with diffuse NPSLE admitted to our University Hospital from 1992 to 2012 were exhaustively enrolled in this study. Their medical charts and brain MRI scans were reviewed. The relationship of MRI abnormalities with various parameters was analysed. RESULTS: As many as 25 of 53 patients (47.2%) had abnormal MRI findings. MRI findings improved after treatment in 10 of 17 patients for whom follow-up studies were available. MRI abnormalities were not correlated with age at the onset of diffuse NPSLE. However, the disease duration of SLE was significantly longer in patients with abnormal MRI findings (p=0.0009). MRI abnormalities were not significantly associated with serum autoantibodies. However, there were significant elevations of the CSF protein level (p=0.0106) and the CSF interleukin 6 level (p=0.0225) in patients with abnormal MRI findings. Patients with MRI abnormalities showed significantly higher overall mortality (p=0.0348). CONCLUSIONS: The results revealed that MRI abnormalities in diffuse NPSLE might be heterogeneous with regard to their reversibility. These data also indicate that patients with diffuse NPSLE and MRI abnormalities have more severe inflammation in the central nervous system related to the activity of diffuse NPSLE, as evidenced by poorer prognosis. |
format | Online Article Text |
id | pubmed-4225739 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-42257392014-11-13 Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus Arinuma, Yoshiyuki Kikuchi, Hirotoshi Wada, Tatsuhiko Nagai, Tatsuo Tanaka, Sumiaki Oba, Hiroshi Hirohata, Shunsei Lupus Sci Med Immunology and Inflammation BACKGROUND: Manifestations in neuropsychiatric systemic lupus erythematosus (NPSLE), especially active diffuse NPSLE syndromes, are some of the most difficult complications of the disease. For the evaluation and the diagnosis of central nervous system manifestations, including NPSLE, MRI is a very useful tool to detect the various abnormalities. However, the relationship between brain MRI findings and clinical variables has not yet been clarified in patients with diffuse NPSLE. OBJECTIVES: The aim of this study is to investigate the pathogenesis of diffuse NPSLE, by comparing various parameters such as serum autoantibodies and cytokines in cerebrospinal fluid (CSF) with abnormal findings revealed on brain MRIs in patients with diffuse NPSLE. METHODS: Fifty-three patients with diffuse NPSLE admitted to our University Hospital from 1992 to 2012 were exhaustively enrolled in this study. Their medical charts and brain MRI scans were reviewed. The relationship of MRI abnormalities with various parameters was analysed. RESULTS: As many as 25 of 53 patients (47.2%) had abnormal MRI findings. MRI findings improved after treatment in 10 of 17 patients for whom follow-up studies were available. MRI abnormalities were not correlated with age at the onset of diffuse NPSLE. However, the disease duration of SLE was significantly longer in patients with abnormal MRI findings (p=0.0009). MRI abnormalities were not significantly associated with serum autoantibodies. However, there were significant elevations of the CSF protein level (p=0.0106) and the CSF interleukin 6 level (p=0.0225) in patients with abnormal MRI findings. Patients with MRI abnormalities showed significantly higher overall mortality (p=0.0348). CONCLUSIONS: The results revealed that MRI abnormalities in diffuse NPSLE might be heterogeneous with regard to their reversibility. These data also indicate that patients with diffuse NPSLE and MRI abnormalities have more severe inflammation in the central nervous system related to the activity of diffuse NPSLE, as evidenced by poorer prognosis. BMJ Publishing Group 2014-11-03 /pmc/articles/PMC4225739/ /pubmed/25396069 http://dx.doi.org/10.1136/lupus-2014-000050 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Immunology and Inflammation Arinuma, Yoshiyuki Kikuchi, Hirotoshi Wada, Tatsuhiko Nagai, Tatsuo Tanaka, Sumiaki Oba, Hiroshi Hirohata, Shunsei Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus |
title | Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus |
title_full | Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus |
title_fullStr | Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus |
title_full_unstemmed | Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus |
title_short | Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus |
title_sort | brain mri in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus |
topic | Immunology and Inflammation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225739/ https://www.ncbi.nlm.nih.gov/pubmed/25396069 http://dx.doi.org/10.1136/lupus-2014-000050 |
work_keys_str_mv | AT arinumayoshiyuki brainmriinpatientswithdiffusepsychiatricneuropsychologicalsyndromesinsystemiclupuserythematosus AT kikuchihirotoshi brainmriinpatientswithdiffusepsychiatricneuropsychologicalsyndromesinsystemiclupuserythematosus AT wadatatsuhiko brainmriinpatientswithdiffusepsychiatricneuropsychologicalsyndromesinsystemiclupuserythematosus AT nagaitatsuo brainmriinpatientswithdiffusepsychiatricneuropsychologicalsyndromesinsystemiclupuserythematosus AT tanakasumiaki brainmriinpatientswithdiffusepsychiatricneuropsychologicalsyndromesinsystemiclupuserythematosus AT obahiroshi brainmriinpatientswithdiffusepsychiatricneuropsychologicalsyndromesinsystemiclupuserythematosus AT hirohatashunsei brainmriinpatientswithdiffusepsychiatricneuropsychologicalsyndromesinsystemiclupuserythematosus |